An incurable disease
A new book explains how health care can become both more expensive and more affordable
HEALTH-CARE expenditure in America is growing at a disturbing rate: in 1960 it was just over 5% of GDP, in 2011 almost 18%. By 2105 the number could reach 60%, according to William Baumol of New York University’s Stern School of Business. Incredible? It is simply the result of extrapolating the impact of a phenomenon Mr Baumol has become famous for identifying: “cost disease”. His new book* gives a nuanced diagnosis, offerings both a vision of a high-cost future and a large dose of optimism. The cost disease may be incurable, but it is also survivable—if treated correctly.
This article appeared in the Finance & economics section of the print edition under the headline “An incurable disease”
More from Finance and economics
![](https://cdn.statically.io/img/www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/media-assets/image/20240803_FNP003.jpg)
India’s economic policy will not make it rich
A new World Bank report takes aim at emerging-market growth plans
![](https://cdn.statically.io/img/www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/media-assets/image/20230715_WOP001.jpg)
Wanted: new business, finance and economics interns
The Economist invites applications for the 2024-25 Marjorie Deane internship
![](https://cdn.statically.io/img/www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/media-assets/image/20240803_FNP503.jpg)
Which cities have the worst overtourism problem?
We rank popular destinations on two measures
Gary Gensler is the most controversial man in American finance
Donald Trump is just the latest to take a swing. In an interview with The Economist, the SEC chair defends his record
EU handouts have long been wasteful. Now they must be fixed
New research highlights their failures
Investors beware: summer madness is here
This year’s hottest months are shaping up to be especially wild